Daniel Eliote Eliote Mbanze

Mr. Daniel Eliote Eliote Mbanze

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2026 in Life
Verified
Journal Article
Open access
PDF file
JOJorge Otero
Jorge Otero
MRMiguel A. Rodríguez-Lázaro
Miguel A. Rodríguez-Lázaro
RSRaffaella Salama
Raffaella Salama
DMDaniel Eliote Eliote Mbanze
Daniel Eliote Eliote Mbanze
GAGorka Solana Arteche
Gorka Solana Arteche
RFRamon Farre
Ramon Farre
Very prevalent respiratory and cardiovascular diseases result in chronic hypoxia, promoting metabolic, kidney, heart, and other malignant diseases. Hypoxia research employs animal models based on chronically breathing hypoxic air (O2 < 21%), usually by injecting N2 into the animal’s chamber. However, continuous high-flow N2 supply is available only in limited facilities, reducing the capability for hypoxia research to be widely conducted. Here, we describe an optimized setting for subjecting rodents to chronic normobaric hypoxia by requiring minimal N2 supply. The primary aim of this study was the technical development and optimization of a system for chronic normobaric hypoxia exposure rather than testing a specific biological hypothesis The setting is based on providing the O2 consumed by the animals and eliminating the exhaled CO2 and water vapor. O2, CO2, temperature, and humidity in the hypoxic chamber are controlled by an Arduino-based unit activating a pump that introduces room air to restore the metabolized O2. Another pump continuously recirculates the chamber air through a Peltier-based dryer and CO2-absorbing soda lime. To correct any deviation in the actual value of hypoxia within the chamber, the control unit allows the injection of N2 into the chamber from a gas source. The setting performance was successfully tested in vivo when subjecting mice to 11%–O2 chronic hypoxia. This device, requiring a low N2 supply, may facilitate in vivo experimental research on hypoxia-related diseases.